Suppr超能文献

描述德国近 20 年的查加斯病及其经验教训:一项回顾性研究,研究了 2000-2018 年期间克氏锥虫感染的筛查、检测、诊断和治疗。

Describing nearly two decades of Chagas disease in Germany and the lessons learned: a retrospective study on screening, detection, diagnosis, and treatment of Trypanosoma cruzi infection from 2000 - 2018.

机构信息

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.

Center for International Health, University Hospital, LMU Munich, Munich, Germany.

出版信息

BMC Infect Dis. 2020 Dec 3;20(1):919. doi: 10.1186/s12879-020-05600-8.

Abstract

BACKGROUND

The highly complex and largely neglected Chagas disease (CD) has become a global health problem due to population movements between Latin America and non-endemic countries, as well as non-vectorial transmission routes. Data on CD testing and treatment from routine patient care in Germany of almost two decades was collected and analysed.

METHODS

German laboratories offering diagnostics for chronic Trypanosoma cruzi (T. cruzi) infection in routine patient care were identified. All retrievable data on tests performed during the years of 2000-2018 were analysed. Additional clinical information regarding patients diagnosed with CD was collected through questionnaires.

RESULTS

Five German laboratories with diagnostics for T. cruzi infection in routine patient care were identified. Centres in Hamburg and Munich offered two independent serological tests to confirm the CD diagnosis, as recommended by WHO during the entire time period 2000-2018. Overall, a total of n = 10,728 independent tests involving n = 5991 individuals were identified with a progressive increase in testing rates over time, only n = 130 (16.0%) of the tested individuals with known nationality came from CD endemic countries. Of all test units conducted at the included institutes, a total of n = 347/10,728 (3.2%) tests on CD were positive, of which n = 200/347 (57.6%) were ELISA, n = 133/347 (38.3%) IFT, n = 10/347 (2.9%) PCR, and n = 4/347 (1.2%) RDT. Of the n = 5991 individuals only n = 81 (1.4%) with chronic infection were identified, n = 52 females and n = 28 males. Additional clinical information could only be collected from n = 47.

CONCLUSION

The results of this study give insight into the deployment of screening, detection, diagnosis, and treatment of T. cruzi over the last two decades in Germany and existing deficits therein; the creation of guidelines for Germany could be a step forward to improve the existing gaps.

摘要

背景

由于拉丁美洲与非流行国家之间的人口流动以及非媒介传播途径,原本复杂且在很大程度上被忽视的恰加斯病(Chagas disease,CD)已成为全球卫生问题。本研究收集并分析了过去近 20 年德国常规患者护理中 CD 检测和治疗的数据。

方法

确定了德国常规患者护理中提供慢性克氏锥虫(Trypanosoma cruzi,T. cruzi)感染诊断的实验室。分析了 2000 年至 2018 年期间进行的所有可检索检测数据。通过问卷调查收集了与确诊 CD 患者相关的额外临床信息。

结果

确定了德国常规患者护理中具有 T. cruzi 感染诊断能力的 5 个实验室。汉堡和慕尼黑的两个中心在 2000 年至 2018 年期间,按照世界卫生组织(World Health Organization,WHO)的建议提供了两种独立的血清学检测来确认 CD 诊断。总体而言,共发现了 n=10728 项独立检测,涉及 n=5991 人,检测率随时间呈渐进式增长,仅有 n=130(16.0%)的已知国籍检测者来自 CD 流行国家。在纳入研究所进行的所有检测单位中,总共 n=347/10728(3.2%)检测结果为阳性,其中 n=200/347(57.6%)为 ELISA,n=133/347(38.3%)为间接免疫荧光试验(IFT),n=10/347(2.9%)为聚合酶链反应(PCR),n=4/347(1.2%)为快速检测试剂(RDT)。在 n=5991 人中,仅发现 n=81(1.4%)慢性感染者,其中女性 n=52 人,男性 n=28 人。仅能从 n=47 人处收集到额外的临床信息。

结论

本研究结果深入了解了过去 20 年德国在 T. cruzi 筛查、检测、诊断和治疗方面的应用情况以及存在的缺陷;为德国制定指南可能是改善现有差距的一个步骤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d5ca/7713040/95eebb658dc3/12879_2020_5600_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验